Merck KGaA (FRA:MRKC)

Market Cap	45.67B -22.8%
Revenue (ttm)	21.10B -0.3%
Net Income	2.61B -6.1%
EPS	6.00 -6.1%
Shares Out	n/a
PE Ratio	17.51
Forward PE	13.50
Dividend	0.30 (1.42%)
Ex-Dividend Date	Apr 29, 2025

Volume	n/a
Average Volume	n/a
Open	21.00
Previous Close	20.80
Day's Range	21.00 - 21.00
52-Week Range	20.20 - 26.40
Beta	n/a
RSI	37.48
Earnings Date	Mar 5, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 59,077
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MRKC

Financial Performance

In 2025, Merck KGaA's revenue was 21.10 billion, a decrease of -0.26% compared to the previous year's 21.16 billion. Earnings were 2.61 billion, a decrease of -6.09%.